SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
AMENDMENT NO. 1
ON
FORM 8-A/A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
Bentley Pharmaceuticals, Inc.
----------------------------------------
(Exact Name of Registrant as Specified in its Charter)
Florida 59-1513162
- ----------------------- -------------------
(State of Incorporation (I.R.S. Employer
or Organization) Identification No.)
4830 West Kennedy Boulevard, One Urban Centre, Suite 550, Tampa, Florida 33609
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
If this Form relates to the If this Form relates to the registration
registration of a class of debt of a class of debt securities and is to
securities and is effective upon become effective simultaneously with the
filing pursuant to General effectiveness of a concurrent registra-
Instruction A(c)(1) please check tion statement under the Securities Act
the following box. [ ] of 1933 pursuant to General Instruction
A (c) (2), please check the following
box. [ ]
Securities to be registered pursuant to Section 12(b) of the Act:
Title of Each Class Name of Each Exchange on Which
to be so Registered Each Class is to be Registered
Units American Stock Exchange/Pacific Stock Exchange
Debentures American Stock Exchange/Pacific Stock Exchange
Class A Redeemable Warrants American Stock Exchange/Pacific Stock Exchange
- --------------------------- ----------------------------------------------
Securities to be registered pursuant to Section 12(g) of the Act: None.
<PAGE>
Item 1. Description of Registrant's Securities to be Registered.
Information required by this Item 1 relating to the Registrant's
Units, Debentures and Class A Redeemable Warrants is incorporated by reference
to Amendment No. 1 to the Registrant's Registration Statement on Form S-1 (File
No. 33-65125) that was filed with the Securities and Exchange Commission on
January 30, 1996, under the sections captioned "Description of Securities," and
"Description of Debentures," on pages 49-53 and 54-58, respectively, of the
prospectus contained therein.
-2-
<PAGE>
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities
Exchange Act of 1934, the registrant has duly caused this registration statement
to be signed on its behalf by the undersigned, thereto duly authorized.
BENTLEY PHARMACEUTICALS, INC.
Date: February 7, 1996 By: /s/ Michael D. Price
-------------------------------------------
Michael D. Price
Vice President and Chief Financial Officer
-3-
